Daniel mentioned on Thursday, different regions have different requirements for ethics approval, even within Australian states. He suggested that South Korea seem to be pretty switched on with ease of approvals etc, whichever region gives approval first will get the resources needed to push the trial as quickly as possible. With this in mind, if SK were to give approval before Xmas, there could potentially be first readouts early in the new year. This could then lead into a potential regional agreement.
Anyway you look at it, great, good or average news is just around the corner, it could very well catch the market napping.
RAC Price at posting:
$1.94 Sentiment: Buy Disclosure: Held
(20min delay)